Mersana (MRSN) PT Lowered to $10 at BTIG, 'Clinical Hold Might Be Manageable'
Tweet Send to a Friend
BTIG analyst Kaveri Pohlman lowered the price target on Mersana (NASDAQ: MRSN) to $10.00 (from $16.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
